A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Clinical trial NCT06943521 · RECRUITING

Trial details

NCT number: NCT06943521
Sponsor: Tanabe Pharma America, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer Gastric Cancer Biliary Tract Cancer Pancreatic Ductal Adenocarcinoma (PDAC)Breast Cancer Ovarian Cancer Cervical Cancer Endometrial Cancer Prostate Cancer Urothelial Carcinoma

Start date: 2025-04-18
Primary completion: 2028-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.